小儿侵袭性曲霉病
Pediatric Invasive Aspergillosis.
作者信息
Wattier Rachel L, Ramirez-Avila Lynn
机构信息
Department of Pediatrics, Division of Infectious Diseases and Global Health, University of California-San Francisco, 550 16th St, 4th Floor, Box 0434, San Francisco, CA 94143, USA.
出版信息
J Fungi (Basel). 2016 Jun 13;2(2):19. doi: 10.3390/jof2020019.
Abstract
Invasive aspergillosis (IA) is a disease of increasing importance in pediatrics due to growth of the immunocompromised populations at risk and improvements in long-term survival for many of these groups. While general principles of diagnosis and therapy apply similarly across the age spectrum, there are unique considerations for clinicians who care for children and adolescents with IA. This review will highlight important differences in the epidemiology, clinical manifestations, diagnosis, and therapy of pediatric IA.
摘要
侵袭性曲霉病（IA）在儿科中的重要性日益增加，这是由于免疫功能低下的高危人群不断增多，且其中许多群体的长期生存率有所提高。虽然诊断和治疗的一般原则在各个年龄段大致相同，但对于照顾患有IA的儿童和青少年的临床医生来说，仍有一些独特的考虑因素。本综述将重点介绍儿童IA在流行病学、临床表现、诊断和治疗方面的重要差异。
相似文献
1
Pediatric Invasive Aspergillosis.
J Fungi (Basel). 2016 Jun 13;2(2):19. doi: 10.3390/jof2020019.
2
Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.
Pediatrics. 2006 Apr;117(4):e711-6. doi: 10.1542/peds.2005-1161. Epub 2006 Mar 13.
3
Invasive aspergillosis in children with hematological malignancies.
Expert Rev Anti Infect Ther. 2011 Mar;9(3):299-306. doi: 10.1586/eri.10.177.
4
Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
J Pediatr Hematol Oncol. 2009 Sep;31(9):642-6. doi: 10.1097/MPH.0b013e3181acd956.
5
Diagnostic Approaches for Invasive Aspergillosis-Specific Considerations in the Pediatric Population.
Front Microbiol. 2018 Mar 26;9:518. doi: 10.3389/fmicb.2018.00518. eCollection 2018.
6
Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases.
J Pediatr Hematol Oncol. 2003 Apr;25(4):286-91. doi: 10.1097/00043426-200304000-00004.
7
Invasive aspergillosis in developing countries.
Med Mycol. 2011 Apr;49 Suppl 1:S35-47. doi: 10.3109/13693786.2010.505206. Epub 2010 Aug 18.
8
Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cochrane Database Syst Rev. 2015 Sep 7(9):CD009551. doi: 10.1002/14651858.CD009551.pub2.
9
Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cochrane Database Syst Rev. 2015 Oct 1(10):CD009551. doi: 10.1002/14651858.CD009551.pub3.
10
Clinical Features and Survival Outcomes of Invasive Aspergillosis in Pediatric Patients at a Medical School in Thailand.
J Med Assoc Thai. 2016 Feb;99(2):150-8.
引用本文的文献
1
Aspergillus-related immune reconstitution inflammatory syndrome in pediatric cancer patients, clinical characteristics, imaging findings, and survival.
BMC Infect Dis. 2024 Dec 18;24(1):1423. doi: 10.1186/s12879-024-10298-z.
2
Recurrent massive hemoptysis from distal pulmonary pseudoaneurysms complicating invasive aspergillosis in a teenager.
Radiol Case Rep. 2022 Aug 11;17(10):3897-3902. doi: 10.1016/j.radcr.2022.07.095. eCollection 2022 Oct.
3
Invasive Aspergillosis in Pediatric Leukemia Patients: Prevention and Treatment.
J Fungi (Basel). 2019 Feb 11;5(1):14. doi: 10.3390/jof5010014.
本文引用的文献
1
Utility of voriconazole therapeutic drug monitoring: a meta-analysis.
J Antimicrob Chemother. 2016 Jul;71(7):1786-99. doi: 10.1093/jac/dkw099. Epub 2016 May 10.
2
Imaging fungal infections in children.
Clin Transl Imaging. 2016;4:57-72. doi: 10.1007/s40336-015-0159-2. Epub 2016 Jan 25.
3
Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?
Mycoses. 2016 Feb;59(2):67-74. doi: 10.1111/myc.12443. Epub 2015 Dec 14.
4
Galactomannan detection for invasive aspergillosis in immunocompromised patients.
Cochrane Database Syst Rev. 2015 Dec 30;2015(12):CD007394. doi: 10.1002/14651858.CD007394.pub2.
5
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.
6
Prognostic Factors in the Outcome of Invasive Fungal Sinusitis in a Pediatric Population.
Pediatr Infect Dis J. 2016 Apr;35(4):384-6. doi: 10.1097/INF.0000000000001015.
7
Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal Fluid.
J Clin Microbiol. 2016 Feb;54(2):428-31. doi: 10.1128/JCM.02913-15. Epub 2015 Dec 9.
8
A Crusted Papule in a Premature Neonate. Cutaneous fungal infection.
JAMA Pediatr. 2015 Dec;169(12):1173-4. doi: 10.1001/jamapediatrics.2015.1359.
9
Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study.
J Pediatric Infect Dis Soc. 2012 Jun;1(2):125-35. doi: 10.1093/jpids/pis042. Epub 2012 May 3.
10
A Prospective, International Cohort Study of Invasive Mold Infections in Children.
J Pediatric Infect Dis Soc. 2015 Dec;4(4):313-22. doi: 10.1093/jpids/piu074. Epub 2014 Jul 16.
Zotero 插件